Ascendis Pharma Derivative Contract Liabilities (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

228.38 +3.38 (+1.50%) USD | NASDAQ | Feb 23, 10:13

View Derivative Contract Liabilities (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	--
Evaxion AS	--
DBV Technologies SA	--
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	--